BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15182425)

  • 1. Thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor-specific antigen.
    Tsujimura K; Obata Y; Takahashi T
    Cancer Sci; 2004 Jun; 95(6):469-74. PubMed ID: 15182425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymus leukemia antigen (TL)-specific cytotoxic T lymphocytes recognize the alpha1/alpha2 domain of TL free from antigenic peptides.
    Tsujimura K; Obata Y; Kondo E; Nishida K; Matsudaira Y; Akatsuka Y; Kuzushima K; Takahashi T
    Int Immunol; 2003 Nov; 15(11):1319-26. PubMed ID: 14565930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of thymus leukemia (TL) antigen tetramers to normal intestinal intraepithelial lymphocytes and thymocytes.
    Tsujimura K; Obata Y; Matsudaira Y; Ozeki S; Yoshikawa K; Saga S; Takahashi T
    J Immunol; 2001 Jul; 167(2):759-64. PubMed ID: 11441080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epitope detected by cytotoxic T lymphocytes against thymus leukemia (TL) antigen is TAP independent.
    Tsujimura K; Obata Y; Iwase S; Matsudaira Y; Ozeki S; Takahashi T
    Int Immunol; 2000 Sep; 12(9):1217-25. PubMed ID: 10967016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive selection of gamma delta CTL by TL antigen expressed in the thymus.
    Tsujimura K; Takahashi T; Morita A; Hasegawa-Nishiwaki H; Iwase S; Obata Y
    J Exp Med; 1996 Dec; 184(6):2175-84. PubMed ID: 8976173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
    Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
    J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.
    Yokouchi H; Chamoto K; Wakita D; Noguchi D; Yamazaki K; Dosaka-Akita H; Nishimura M; Ikeda H; Nishimura T
    Cancer Sci; 2006 Feb; 97(2):148-54. PubMed ID: 16441426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.
    Hess SM; Young EF; Miller KR; Vincent BG; Buntzman AS; Collins EJ; Frelinger JA; Hess PR
    Transpl Immunol; 2013 Dec; 29(1-4):138-45. PubMed ID: 24161680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thymus leukemia antigen binds human and mouse CD8.
    Teitell M; Mescher MF; Olson CA; Littman DR; Kronenberg M
    J Exp Med; 1991 Nov; 174(5):1131-8. PubMed ID: 1834760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.
    Parkhurst MR; DePan C; Riley JP; Rosenberg SA; Shu S
    J Immunol; 2003 May; 170(10):5317-25. PubMed ID: 12734382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement.
    Lask A; Goichberg P; Cohen A; Goren-Arbel R; Milstein O; Aviner S; Feine I; Ophir E; Reich-Zeliger S; Hagin D; Klein T; Nagler A; Berrebi A; Reisner Y
    J Immunol; 2011 Aug; 187(4):2006-14. PubMed ID: 21753148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes.
    Johnston JV; Malacko AR; Mizuno MT; McGowan P; Hellström I; Hellström KE; Marquardt H; Chen L
    J Exp Med; 1996 Mar; 183(3):791-800. PubMed ID: 8642283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and specificity of T cell receptor gamma/delta on major histocompatibility complex antigen-specific CD3+, CD4-, CD8- T lymphocytes.
    Bluestone JA; Cron RQ; Cotterman M; Houlden BA; Matis LA
    J Exp Med; 1988 Nov; 168(5):1899-916. PubMed ID: 2846743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
    André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
    J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
    J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymus-leukemia antigen interacts with T cells and self-peptides.
    Sharma P; Joyce S; Chorney KA; Griffith JW; Bonneau RH; Wilson FD; Johnson CA; Flavell RA; Chorney MJ
    J Immunol; 1996 Feb; 156(3):987-96. PubMed ID: 8558026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells.
    Morita A; Takahashi T; Stockert E; Nakayama E; Tsuji T; Matsudaira Y; Old LJ; Obata Y
    J Exp Med; 1994 Mar; 179(3):777-84. PubMed ID: 8113675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.